☆ 4.8 Article

Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors

NATURE COMMUNICATIONS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Compstatins: the dawn of clinical C3-targeted complement inhibition

Christina Lamers et al.

Summary: This review discusses the importance of the complement system in the treatment of clinical conditions and the development of treatment methods, focusing on targeted therapy of C3 activation and highlighting the critical role of pegcetacoplan as a C3 inhibitor in treating complement diseases.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

添加到收藏夹

Editorial Material Immunology

From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors

Dimitrios C. Mastellos et al.

Summary: The FDA approval of pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria is a significant milestone in complement drug discovery, as it offers patients an alternative treatment option with a distinct mechanism of action.

CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101

Panagiotis Skendros et al.

Summary: Complement C3 activation plays a role in the pathology of COVID-19, and targeting C3 has emerged as a promising therapeutic strategy. This study provides interim data from the first randomized trial evaluating a C3 inhibitor, AMY-101, in severe COVID-19 patients. The results show that AMY-101 is safe and well tolerated, and it appears to have a potential benefit in reducing disease severity.

SCIENCE ADVANCES (2022)

添加到收藏夹

Article Hematology

Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity

Marco Mannes et al.

Summary: Use of C5 inhibitor eculizumab to block the terminal complement pathway has revolutionized clinical management of complement-mediated diseases. New findings show that C3/C5 convertases function differently than previously thought, with C3 inhibition not necessarily leading to C5 inhibition. Surface-deposited C4b alone can recruit and activate C5, and only C5 bound on C3b/C4b-decorated surfaces requires surface fixation for activation.

BLOOD (2021)

添加到收藏夹

Review Immunology

Tipping the balance: intricate roles of the complement system in disease and therapy

Richard B. Pouw et al.

Summary: The complement system plays a crucial role in host defense and surveillance by rapidly and broadly targeting microbial invaders, apoptotic cells, and other threats, but can also cause harm in various immune, inflammatory, age-related, or biomaterial-induced conditions. Despite its long association with disease, the prevalence, impact, and complexity of complement's involvement in pathological processes is only now being fully recognized.

SEMINARS IN IMMUNOPATHOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen et al.

Summary: The study demonstrated that Pegcetacoplan was superior to eculizumab in improving hemoglobin and clinical and hematologic outcomes in patients with PNH by providing broad hemolysis control, including control of intravascular and extravascular hemolysis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammation

Hatice Hasturk et al.

Summary: The study evaluated the efficacy and safety of a complement 3-targeted therapeutic, AMY-101, for gingival inflammation in adult patients. Results showed that AMY-101 significantly reduced gingival inflammation and the effects persisted for at least 3 months.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Letter Hematology

Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells

Inge Baas et al.

HAEMATOLOGICA (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Computational analysis of complement inhibitor compstatin using molecular dynamics

Didier Devaurs et al.

JOURNAL OF MOLECULAR MODELING (2020)

添加到收藏夹

Article Hematology

C3inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab

Carlos de Castro et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

添加到收藏夹

Article Immunology

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Dimitrios C. Mastellos et al.

CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Clinical promise of next-generation complement therapeutics

Dimitrios C. Mastellos et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Article Immunology

Complement Nomenclature - Deconvoluted

Suzanne S. Bohlson et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Chemistry, Medicinal

New Analogs of the Complement C3 Inhibitor Compstatin with Increased Solubility and Improved Pharmacokinetic Profile

Nadja Berger et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

SWISS-MODEL: homology modelling of protein structures and complexes

Andrew Waterhouse et al.

NUCLEIC ACIDS RESEARCH (2018)

添加到收藏夹

Editorial Material Hematology

Novel Immunoassay for Complement Activation by PF4/Heparin Complexes

Sanjay Khandelwal et al.

THROMBOSIS AND HAEMOSTASIS (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Complement C3 inhibitor Cp40 attenuates xenoreactions in pig hearts perfused with human blood

Jan-Michael Abicht et al.

XENOTRANSPLANTATION (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses

Xiaoguang Xue et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses

Xiaoguang Xue et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)

添加到收藏夹

Article Immunology

Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40

Junxiang Wang et al.

CLINICAL IMMUNOLOGY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode

Federico Forneris et al.

EMBO JOURNAL (2016)

添加到收藏夹

Article Immunology

Rare Loss-of-Function Mutation in Complement Component C3 Provides Insight into Molecular and Pathophysiological Determinants of Complement Activity

Georgia Sfyroera et al.

JOURNAL OF IMMUNOLOGY (2015)

添加到收藏夹

Article Hematology

Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria

Antonio M. Risitano et al.

BLOOD (2014)

添加到收藏夹

Review Hematology

Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape

Dimitrios C. Mastellos et al.

EXPERT REVIEW OF HEMATOLOGY (2014)

添加到收藏夹

Article Biochemical Research Methods

How good are my data and what is the resolution?

Philip R. Evans et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)

添加到收藏夹

Article Immunology

New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties

Hongchang Qu et al.

IMMUNOBIOLOGY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

添加到收藏夹

Article Immunology

Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting Properties

Christoph Q. Schmidt et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg

Goran Bajic et al.

PROTEIN SCIENCE (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Novel analogues of the therapeutic complement inhibitor compstatin with significantly improved affinity and potency

Hongchang Qu et al.

MOLECULAR IMMUNOLOGY (2011)

添加到收藏夹

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

添加到收藏夹

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

添加到收藏夹

Article Biochemical Research Methods

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Paul D. Adams et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)

添加到收藏夹

Article Multidisciplinary Sciences

Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation

Federico Forneris et al.

SCIENCE (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatin

Paola Magotti et al.

JOURNAL OF MOLECULAR RECOGNITION (2009)

添加到收藏夹

Article Immunology

Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor

Suzan H. M. Rooijakkers et al.

NATURE IMMUNOLOGY (2009)

添加到收藏夹

Article Immunology

Structure of complement fragment C3b-factor H and implications for host protection by complement regulators

Jin Wu et al.

NATURE IMMUNOLOGY (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition

Bert J. C. Janssen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

添加到收藏夹

Article Chemistry, Multidisciplinary

Phaser crystallographic software

Airlie J. McCoy et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Factor B structure provides insights into activation of the central protease of the complement system

Fin J. Milder et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of C3b reveals conformational changes that underlie complement activity

Bert J. C. Janssen et al.

NATURE (2006)

添加到收藏夹

Article Chemistry, Medicinal

Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin

Madan Katragadda et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

添加到收藏夹

Article Multidisciplinary Sciences

Structures of complement component C3 provide insights into the function and evolution of immunity

BJC Janssen et al.

NATURE (2005)

添加到收藏夹

Article Immunology

Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins

G Sfyroera et al.

JOURNAL OF IMMUNOLOGY (2005)

添加到收藏夹

Article Chemistry, Medicinal

Design and NMR characterization of active analogues of compstatin containing non-natural amino acids

B Mallik et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

添加到收藏夹

Article Biochemistry & Molecular Biology

Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3

A Sahu et al.

MOLECULAR IMMUNOLOGY (2003)

添加到收藏夹

Article Immunology

Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin

A Sahu et al.

JOURNAL OF IMMUNOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.